Management of complications arising from the use of mesh for stress urinary incontinence-International Urogynecology Association Research and Development Committee opinion.


Journal

International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041

Informations de publication

Date de publication:
09 2019
Historique:
received: 26 09 2018
accepted: 14 03 2019
pubmed: 29 3 2019
medline: 9 4 2020
entrez: 29 3 2019
Statut: ppublish

Résumé

Management of pain or mesh exposure complications after stress incontinence surgery has become a new issue over the last 20 years with the introduction of mesh techniques to treat stress incontinence. There is much debate regarding the incidence of complications and how best to treat them. A working subcommittee from the International Urogynecology Association (IUGA) Research and Development (R&D) Committee was formed. An initial document was drafted based on a literature review. The review focused on complications of vaginal mesh inserted for stress incontinence. After evaluation by the entire IUGA R&D Committee revisions were made. The final document represents the IUGA R&D Committee Opinion. The R&D Committee Opinion reviews the literature on the management of complications arising from the use of mesh for stress urinary incontinence. The review concentrated on the assessment and treatment of pain and exposure. Complications after surgery for stress incontinence using mesh may not be common occurrences for individual surgeons. Complications may be difficult to manage and outcomes are variable. Specialist centres and a multidisciplinary approach may optimise treatment and reporting of outcomes.

Identifiants

pubmed: 30918979
doi: 10.1007/s00192-019-03935-8
pii: 10.1007/s00192-019-03935-8
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1413-1417

Références

Expert Rev Med Devices. 2015 Mar;12(2):201-16
pubmed: 25483725
Sci Rep. 2017 Sep 20;7(1):12015
pubmed: 28931856
Indian J Urol. 2012 Apr;28(2):129-53
pubmed: 22919127
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jun;19(6):857-61
pubmed: 18188489
J Urol. 2018 Jun;199(6):1571-1576
pubmed: 29288123
Urol Clin North Am. 2012 Aug;39(3):413-8
pubmed: 22877725
Int Urogynecol J. 2011 Apr;22(4):439-41
pubmed: 21060989
Int Urogynecol J. 2018 Jun;29(6):859-864
pubmed: 28695345
Int Urogynecol J. 2017 Jul;28(7):989-992
pubmed: 27924372
Am J Obstet Gynecol. 2010 May;202(5):481.e1-5
pubmed: 20227671
Int Urogynecol J. 2014 Mar;25(3):313-8
pubmed: 24217793
Eur Urol Focus. 2016 Aug;2(3):260-267
pubmed: 28723371
Radiographics. 2016 Jul-Aug;36(4):1233-56
pubmed: 27399245
J Minim Invasive Gynecol. 2011 Nov-Dec;18(6):769-73
pubmed: 22024263
Int Urogynecol J. 2016 Jun;27(6):879-86
pubmed: 26670575
Neurourol Urodyn. 2016 Mar;35(3):407-11
pubmed: 25620321
Int Urogynecol J. 2019 Aug;30(8):1323-1328
pubmed: 30229269
Lancet. 2017 Feb 11;389(10069):629-640
pubmed: 28010993
Int Urogynecol J Pelvic Floor Dysfunct. 2006 Jun;17(4):330-4
pubmed: 16211316
Am J Obstet Gynecol. 2016 Aug;215(2):206.e1-8
pubmed: 27094962
Best Pract Res Clin Rheumatol. 2011 Apr;25(2):185-98
pubmed: 22094195
Surg Technol Int. 2016 Oct 26;29:185-189
pubmed: 27780347
BJU Int. 2005 Jan;95(1):95-7
pubmed: 15638903
JAMA. 2018 Oct 23;320(16):1659-1669
pubmed: 30357298
Biomed Res Int. 2015;2015:831285
pubmed: 25973425
Am J Obstet Gynecol. 2016 Dec;215(6):764.e1-764.e5
pubmed: 27448731
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jun;19(6):827-31
pubmed: 18183341
Can Urol Assoc J. 2017 Jun;11(6Suppl2):S135-S140
pubmed: 28616113
Int Urogynecol J Pelvic Floor Dysfunct. 2007 Nov;18(11):1371-3
pubmed: 17431534
Int Urogynecol J. 2011 Jan;22(1):3-15
pubmed: 21140130
Int Urogynecol J. 2013 Feb;24(2):195-201
pubmed: 22752013
J Urol. 2012 Jul;188(1):27-32
pubmed: 22578730
Eur J Obstet Gynecol Reprod Biol. 2012 Jun;162(2):224-8
pubmed: 22464208
Int Urogynecol J Pelvic Floor Dysfunct. 2006 Jun;17(4):311
pubmed: 16741602
Int Urogynecol J. 2018 Jan;29(1):23-28
pubmed: 29170815
Korean J Urol. 2010 Sep;51(9):657-9
pubmed: 20856653

Auteurs

Jonathan Duckett (J)

Department of Obstetrics and Gynaecology, Medway Maritime Hospital, Windmill Road, Gillingham, Kent, ME7 5NY, UK. jraduckett@hotmail.com.

Barbara Bodner-Adler (B)

Department of General Gynecology and Gynecologic Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

Suneetha Rachaneni (S)

Department of Urogynaecology, University Hospitals Plymouth NHS Trust, Plymouth, UK.

Pallavi Latthe (P)

Department of Urogynaecology, Birmingham Women's NHS Foundation Trust, Edgbaston, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH